Education Lab/CME

DR
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 6/10/2019
Credit Type(s): CME | Credit: 1.25

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
Proliferative and Non-proliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment
CME

Proliferative and Nonproliferative Diabetic Retinopathy: Weighing the Evidence for Medical Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/26/2019
Credit Type(s): CME | Credit: 0.5

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
J176
CME

Noninfectious Uveitis: Moving Beyond Convention for Long-Term Management

This activity is supported by educational grants from AbbVie, Inc.; Mallinckrodt Pharmaceuticals; and Santen Inc.

Expiration Date: 4/16/2019
Credit Type(s): CME | Credit: 0.75

Noninfectious uveitis is a leading cause of preventable blindness worldwide. To avert potential severe vision loss, a timely diagnosis must be provided, and the…

go to activity»
/sitecore/media library/Images/Education Lab/Top Picks/2018/Ophthalmology/j732_top_pick_280x180
CME

Current Treatment Algorithms for the Management of Dry Eye Disease

This activity is supported by educational grants from Allergan, Inc. and Shire Pharmaceuticals.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.25

Dry eye is a multifactorial disease of the ocular surface characterized by a loss of homeostasis of the tear film, accompanied by ocular symptoms. This CME activity will…

go to activity»
J894
CME

Improving the Clinical Picture of IOP in Glaucoma Through Innovative Treatments

This activity is supported by an educational grant from Bausch + Lomb.

Expiration Date: 4/8/2019
Credit Type(s): CME | Credit: 0.75

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Dry Eye
CME

Treating Inflammation in Dry Eye: The Rule, Not the Exception

This activity is supported by an educational grant from Allergan, Inc.

Expiration Date: 4/3/2019
Credit Type(s): CME | Credit: 0.75

Dry eye disease (DED) is one of the most frequently encountered ocular surface disorders. It is a growing public health problem and one of the most common conditions…

go to activity»
Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment
CME

Reducing IOP and Improving Compliance in 2018: New Opportunities in Medical Glaucoma Treatment

This activity is supported by an educational grant from Aerie Pharmaceuticals, Inc.

Expiration Date: 5/25/2019
Credit Type(s): CME | Credit: 1.25

Glaucoma is the leading cause of irreversible blindness worldwide, with an estimated 70 million people currently affected by the condition. Advances in imaging have…

go to activity»
Ocular Surface
CME

Preserving the Ocular Surface: Practice Pearls Part 3

This activity is supported by educational grants from Allergan, Inc.; Bausch + Lomb; and Shire.

Expiration Date: 4/23/2019
Credit Type(s): CME | Credit: 0.5

Dry eye symptoms are experienced by many patients, especially with aging. Unfortunately, millions of patients with ocular surface disease are underdiagnosed in the…

go to activity»
Macular Degeneration CME
CME

Advancing Science on Age-related Macular Degeneration

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 3/25/2019
Credit Type(s): CME | Credit: 1.25

Age-related macular degeneration (AMD) is one of the leading causes of adult blindness and visual impairment. Because age is a major risk factor for developing AMD, it…

go to activity»
J970
CME

Assessing and Treating Diabetic Retinopathy Amid New Recommendations and Evidence

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 4/9/2019
Credit Type(s): CME | Credit: 0.75

Although rapid advances have been made in the treatment of diabetic macular edema (DME), particularly with the use of intravitreal therapy, options for the management of…

go to activity»
J987
CME

Providing Defense at the Ocular Surface: Managing Dry Eye

This activity is supported by an educational grant from Shire.

Expiration Date: 4/5/2019
Credit Type(s): CME | Credit: 0.75

This CME activity will discuss modalities for diagnosing ocular surface disease as well as assess the attributes and limitations of using dry eye monotherapy and…

go to activity»
J554_02
CME

MIGS Perspectives with Reay H. Brown, MD

This activity is supported by educational grants from Aerie Pharmaceuticals, Inc.; Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

Expiration Date: 3/19/2019
Credit Type(s): CME | Credit: 0.25

Minimally invasive glaucoma surgery (MIGS) is generally safer, with quicker recovery times. This on-the-scene expert interview will describe new advances with MIGS for…

go to activity»